Skip to main content

August 2021 Vol 14, Special Issue: Payers' Perspectives in Oncology

Melanoma, Conference Highlights ASCO, Oncology
Novel LAG-3–Blocking Antibody plus Nivolumab Shows Promise as First-Line Treatment in Advanced Melanoma
Wayne Kuznar
Read More
Prostate Cancer, Conference Highlights ASCO
¹⁷⁷Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer
Phoebe Starr
Read More
Conference Highlights ASCO
Early Phase 3 Results Show Survival Benefit with Nivolumab-Based Regimens in Advanced Esophageal Squamous-Cell Cancer
Wayne Kuznar
Read More
Renal-Cell Carcinoma, Conference Highlights ASCO, Oncology
Adjuvant Pembrolizumab Therapy Significantly Extends Disease-Free Survival in Patients with Clear-Cell Renal-Cell Carcinoma
Phoebe Starr
Read More
Page 2 of 2
Results 11 - 14 of 14